T. Rowe Price Associates
NTNX icon

T. Rowe Price Associates’s Nutanix NTNX Stock Holding History

T. Rowe Price Associates’s Portfolio NTNX Stock Details NTNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19M Sell
500,150
-236,126
-32% -$9.95M ﹤0.01% 1053
2025
Q4 		$38.1M Sell
736,276
-524,084
-42% -$32M ﹤0.01% 888
2025
Q3 		$93.8M Sell
1,260,360
-451,758
-26% -$33.2M 0.01% 638
2025
Q2 		$131M Buy
1,712,118
+510,649
+43% +$36.8M 0.01% 512
2025
Q1 		$83.9M Sell
1,201,469
-587,703
-33% -$40.7M 0.01% 584
2024
Q4 		$109M Sell
1,789,172
-48,656
-3% -$3.18M 0.01% 551
2024
Q3 		$109M Sell
1,837,828
-441,743
-19% -$24.3M 0.01% 550
2024
Q2 		$130M Sell
2,279,571
-2,079,197
-48% -$128M 0.02% 489
2024
Q1 		$269M Buy
4,358,768
+985,421
+29% +$56.8M 0.03% 372
2023
Q4 		$161M Buy
3,373,347
+1,567,417
+87% +$63.4M 0.02% 452
2023
Q3 		$63M Buy
1,805,930
+1,703,211
+1,658% +$53.5M 0.01% 613
2023
Q2 		$2.88M Buy
102,719
+5,632
+6% +$150K ﹤0.01% 1353
2023
Q1 		$2.52M Buy
97,087
+6,527
+7% +$177K ﹤0.01% 1388
2022
Q4 		$2.36M Sell
90,560
-3,571
-4% -$97.5K ﹤0.01% 1406
2022
Q3 		$1.96M Buy
94,131
+5,633
+6% +$103K ﹤0.01% 1462
2022
Q2 		$1.29M Buy
88,498
+2,803
+3% +$58.4K ﹤0.01% 1774
2022
Q1 		$2.3M Buy
85,695
+5,954
+7% +$160K ﹤0.01% 1641
2021
Q4 		$2.54M Sell
79,741
-5,249
-6% -$180K ﹤0.01% 1626
2021
Q3 		$3.2M Buy
84,990
+3,613
+4% +$137K ﹤0.01% 1587
2021
Q2 		$3.11M Buy
81,377
+1,910
+2% +$59.5K ﹤0.01% 1605
2021
Q1 		$2.11M Buy
79,467
+17,131
+27% +$521K ﹤0.01% 1694
2020
Q4 		$1.99M Sell
62,336
-284,485
-82% -$7.72M ﹤0.01% 1638
2020
Q3 		$7.69M Buy
346,821
+292,720
+541% +$6.69M ﹤0.01% 1351
2020
Q2 		$1.28M Sell
54,101
-17,440
-24% -$361K ﹤0.01% 1680
2020
Q1 		$1.13M Sell
71,541
-322,772
-82% -$9.07M ﹤0.01% 1655
2019
Q4 		$12.3M Buy
394,313
+334,456
+559% +$9.88M ﹤0.01% 1279
2019
Q3 		$1.57M Sell
59,857
-1,052,061
-95% -$24.8M ﹤0.01% 1639
2019
Q2 		$28.8M Buy
1,111,918
+1,074,748
+2,891% +$37.5M ﹤0.01% 1064
2019
Q1 		$1.4M Buy
37,170
+6,570
+21% +$301K ﹤0.01% 1710
2018
Q4 		$1.27M Sell
30,600
-382,502
-93% -$15.8M ﹤0.01% 1709
2018
Q3 		$17.6M Buy
413,102
+403,088
+4,025% +$21.3M ﹤0.01% 1270
2018
Q2 		$516K Sell
10,014
-367,345
-97% -$20.2M ﹤0.01% 2125
2018
Q1 		$18.5M Buy
+377,359
New +$15M ﹤0.01% 1210
2017
Q4 		– Sell
-35,965
Closed -$805K – 2595
2017
Q3 		$805K Buy
+35,965
New +$787K ﹤0.01% 1886
2017
Q2 		– Sell
-489,643
Closed -$9.19M – 2572
2017
Q1 		$9.19M Buy
+489,643
New +$13.1M ﹤0.01% 1349
2016
Q4 		– Sell
-650,000
Closed -$24.1M – 2564
2016
Q3 		$24.1M Buy
+650,000
New +$24.1M ﹤0.01% 1066

Other funds holding NTNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

T. Rowe Price Associates's NTNX Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Nutanix (NTNX) stake by 32% in Q1 2026, selling an estimated $9.95M and leaving 500,150 shares worth $19M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

T. Rowe Price Associates first reported a position in NTNX in Q3 2016 and has held it in 36 quarters since. The position peaked at $269M in Q1 2024. 534 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • T. Rowe Price Associates held 500,150 shares of Nutanix worth $19M as of Q1 2026.
  • T. Rowe Price Associates sold 236,126 Nutanix shares in Q1 2026, an estimated $9.95M.
  • Nutanix made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1053 holding.
  • T. Rowe Price Associates first reported a position in Nutanix in Q3 2016 and has held it in 36 quarters since.
  • T. Rowe Price Associates's Nutanix position peaked at $269M in Q1 2024.
  • 534 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.